What was studied Across 37 studies (63 treatment arms, 9,341 adults) with overweight or obesity, the authors quantified how fast #weight returns after #discontinuing #medication, and compared this with regain after behavioural weight-management programmes (#BWMPs)
Despite experiencing metabolic and cardiovascular improvements, many individuals using these drugs might retain underlying conditions such as diabetes, hypertension, dyslipidemia, sleep apnea, or fatty liver disease (MASLD)
Again though, the effects in this regard are likely to be moderate or even clinically insignificant
These studies can provide valuable insights into how skin reactions develop over time and whether they persist or subside with continued use of the medication
They are not to be used for any human or veterinary purposes